Deutsche Bank’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-855
Closed -$76K 4586
2021
Q1
$76K Buy
+855
New +$84.8K ﹤0.01% 4108
2020
Q1
Sell
-861
Closed -$28K 4316
2019
Q4
$28K Buy
+861
New +$27.4K ﹤0.01% 4187

Other funds holding ARKG

Deutsche Bank's ARKG Position: Q2 2021 in Review

Deutsche Bank sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 855 shares — an estimated $76K sold.

Deutsche Bank first reported a position in ARKG in Q4 2019 and held it in 2 quarters. The position peaked at $76K in Q1 2021. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Deutsche Bank reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 855 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $76K.
  • Deutsche Bank first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 2 quarters.
  • Deutsche Bank's ARK Genomic Revolution ETF position peaked at $76K in Q1 2021.
  • 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.